Q Bio Revenue and Competitors

Location

$84M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Q Bio's estimated annual revenue is currently $6M per year.(i)
  • Q Bio's estimated revenue per employee is $131,413
  • Q Bio's total funding is $84M.

Employee Data

  • Q Bio has 46 Employees.(i)
  • Q Bio grew their employee count by -29% last year.

Q Bio's People

NameTitleEmail/Phone
1
Founder/CEO/CTOReveal Email/Phone
2
Co-founder and CEO Reveal Email/Phone
3
VP RadiomicsReveal Email/Phone
4
Head Product Management, GeminiReveal Email/Phone
5
Manager, Patient SupportReveal Email/Phone
6
Software EngineerReveal Email/Phone
7
Software EngineerReveal Email/Phone
8
MRI TechnologistReveal Email/Phone
9
Staff Image Processing EngineerReveal Email/Phone
10
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Q Bio?

The Physical of the Future: Q Bio gives you a deeper understanding of your body and how it's changing, so you have more control over your health. Our Q Exam is based on landmark systems biology research done at Stanford University. In about 75 minutes, we take blood, saliva, urine and a non-invasive whole-body scan from which we measure over 3000 clinically-relevant genetic, chemical, and anatomical biomarkers to build the world's most comprehensive quantitative snapshot of your health at a point in time. We believe people should know more, worry less... and that prevention is better than the best cure.

keywords:Biotechnology, Healthcare

$84M

Total Funding

46

Number of Employees

$6M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Q Bio News

2022-04-20 - INmune Bio, Inc. to Report First Quarter 2022 Financial ...

Please ask for the INmune Bio Third Quarter Conference Call when reaching ... the Company's Quarterly Reports on Form 10-Q and the Company's...

2022-04-20 - Bio-Rad Reports First-Quarter 2022 Financial Results

BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), ... 2021 and its Quarterly Report on Form 10-Q for the quarter ended March...

2022-04-19 - Layoffs hit another biotech as Duchenne player Solid Bio cuts ...

Solid Bio is reducing its workforce by 35%, according to an SEC filing for ... organizational efficiencies,” Solid Bio said in its 10-Q. “We...

2021-04-30 - Q Bio Launches Clinical “Digital Twin” Platform, Whole Body Scanner

What You Should Know: – Q Bio, a Redwood City, CA-based company building technology for the Physical of the Future, unveiled its “digital twin” platform, the first to capture and monitor comprehensive baseline patient health in a scalable virtual model. – In addition, the company announced an ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M460%N/A
#2
$3.6M4612%$102.6M
#3
$5.5M4796%N/A
#4
$13.8M494%N/A
#5
$7.6M49-18%N/A